RetiSpec Email Format
Software DevelopmentOntario, Canada11-50 Employees
RetiSpec is a software development company based in Toronto, Ontario, that focuses on AI-assisted early detection of neurodegenerative diseases through a simple eye exam. Its technology uses retinal imaging to identify signals associated with Alzheimer’s disease, offering a non-invasive and scalable approach intended to aid clinicians in evaluating individuals with cognitive decline. The company operates within the health technology and brain health research space, collaborating with hospitals and research networks across North America to advance clinically validated tests for predicting amyloid burden at the point of care. Founded and staffed to develop AI-driven diagnostic tools, RetiSpec is pursuing regulatory and market entry plans for its first clinically validated test while contributing to multiple Alzheimer’s and brain health studies in the region.